1. Home
  2. SSSS vs RENB Comparison

SSSS vs RENB Comparison

Compare SSSS & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSSS
  • RENB
  • Stock Information
  • Founded
  • SSSS 2010
  • RENB 2011
  • Country
  • SSSS United States
  • RENB United States
  • Employees
  • SSSS N/A
  • RENB N/A
  • Industry
  • SSSS Finance: Consumer Services
  • RENB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSSS Finance
  • RENB Health Care
  • Exchange
  • SSSS Nasdaq
  • RENB Nasdaq
  • Market Cap
  • SSSS 138.2M
  • RENB 62.0M
  • IPO Year
  • SSSS N/A
  • RENB N/A
  • Fundamental
  • Price
  • SSSS $8.37
  • RENB $0.27
  • Analyst Decision
  • SSSS Strong Buy
  • RENB
  • Analyst Count
  • SSSS 3
  • RENB 0
  • Target Price
  • SSSS $9.33
  • RENB N/A
  • AVG Volume (30 Days)
  • SSSS 261.6K
  • RENB 2.2M
  • Earning Date
  • SSSS 08-06-2025
  • RENB 05-15-2025
  • Dividend Yield
  • SSSS 3.01%
  • RENB N/A
  • EPS Growth
  • SSSS N/A
  • RENB N/A
  • EPS
  • SSSS N/A
  • RENB N/A
  • Revenue
  • SSSS $3,644,430.00
  • RENB N/A
  • Revenue This Year
  • SSSS $5,400.03
  • RENB N/A
  • Revenue Next Year
  • SSSS N/A
  • RENB N/A
  • P/E Ratio
  • SSSS N/A
  • RENB N/A
  • Revenue Growth
  • SSSS N/A
  • RENB N/A
  • 52 Week Low
  • SSSS $3.52
  • RENB $0.27
  • 52 Week High
  • SSSS $8.77
  • RENB $2.10
  • Technical
  • Relative Strength Index (RSI)
  • SSSS 67.40
  • RENB 38.03
  • Support Level
  • SSSS $8.31
  • RENB $0.33
  • Resistance Level
  • SSSS $8.35
  • RENB $0.32
  • Average True Range (ATR)
  • SSSS 0.36
  • RENB 0.03
  • MACD
  • SSSS -0.02
  • RENB -0.00
  • Stochastic Oscillator
  • SSSS 73.42
  • RENB 4.84

About SSSS SuRo Capital Corp.

SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.

About RENB Renovaro Biosciences Inc.

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Share on Social Networks: